| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 04/21/2010 | EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists |
| 04/20/2010 | US7700635 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitorsfor seine/threonine kinases, phosphatases; Alzheimer's |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700362 Method for screening therapeutic agents for disuse muscular atrophy using interaction between selected proteins and a polyubiquitin chain |
| 04/20/2010 | CA2352572C Humanized antibodies to gamma-interferon |
| 04/15/2010 | WO2010041681A1 Novel sominone derivative |
| 04/15/2010 | WO2010006086A3 Kinase inhibitors and methods of use |
| 04/15/2010 | US20100093867 Method Of Treating Genetic Disease Caused By Nonsense Mutation |
| 04/15/2010 | US20100093802 Ccr9 inhibitors and methods of use thereof |
| 04/15/2010 | US20100093745 Therapeutic agent or prophylactic agent for demyelinating disease comprising amino alcohol derivative as active ingredient |
| 04/15/2010 | US20100093741 Certain chemical entities, compositions and methods |
| 04/15/2010 | US20100093632 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 04/15/2010 | US20100093622 method of producing native components, such as growth factors or extracellular matrix proteins, through cell culturing of tissue samples for tissue repair |
| 04/15/2010 | US20100093613 Methods for identifying agents and their use for the prevention or stabilization of fibrosis |
| 04/15/2010 | US20100092436 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/14/2010 | EP2174955A1 Ifnar2 muteins, their production and use |
| 04/14/2010 | EP2174954A1 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 04/14/2010 | EP2174949A2 Leucine-based motif and clostridial neurotoxins |
| 04/14/2010 | EP2174662A2 Methods for treating muscle injuries |
| 04/14/2010 | EP2174661A1 Agent for improving dysfunction due to neuropathy and rho kinase activation inhibitor |
| 04/14/2010 | EP2173356A1 Use of 25-hydroxy vitamin d3 to increase muscle mass in mammals |
| 04/14/2010 | EP1294866B1 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation |
| 04/14/2010 | CN101693056A External medicine bag for treating articular osteoid diseases and using method thereof |
| 04/14/2010 | CN101234121B Application of purslane amide alkaloid in preparing antioxidant and neuroprotective agent |
| 04/13/2010 | US7696357 Darifenacin solvate with toluene; mixing the free base with toluene to form the solvate, converting to the hydrate, addition salt formation with hydrogen bromide; high purity, extended shelf life; irritable bowel syndrome, incontinence and other gastrointestinal disorders |
| 04/13/2010 | US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2430363C Compounds and their uses |
| 04/13/2010 | CA2295678C Pyridine derivatives |
| 04/08/2010 | WO2010039823A2 Compositions and methods for tissue repair with extracellular matrices |
| 04/08/2010 | US20100087522 Novel muscle relaxant using negative charge gold nanoparticle with choline |
| 04/08/2010 | US20100087451 Polymorph b of n--n-methyl-acetamide |
| 04/08/2010 | US20100087411 Substituted sapogenins and their use |
| 04/08/2010 | US20100087408 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE |
| 04/08/2010 | US20100087366 Gh secretagogues and uses thereof |
| 04/08/2010 | US20100086559 Polypeptide formulation |
| 04/08/2010 | CA2741770A1 Compositions and methods for tissue repair with extracellular matrices |
| 04/07/2010 | EP2172468A1 Benzimidazolone compounds |
| 04/07/2010 | EP1255824B1 Transgenic mice for the study of neurodegenerative syndromes |
| 04/07/2010 | CN101690800A Externally used medicament for expelling rheumatism, promoting blood circulation and relieving pain and preparation method thereof |
| 04/07/2010 | CN101690776A Chinese medicinal preparation for treating diaphragm muscle spasm |
| 04/06/2010 | US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent |
| 04/06/2010 | US7691974 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/06/2010 | US7691387 Cinnamomi and poria composition, method to prepare same and uses thereof |
| 04/06/2010 | US7691367 A therapeutic polypeptide drug conjugated with two chains of polyoxyethylene glycol, linked to a cyclohexane ring; high molecular weight, stability, nontoxic, sustained release |
| 04/06/2010 | CA2475137C New heterocyclic oxime derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 04/06/2010 | CA2455181C Benzimidazo[4,5-f]isoquinolinone derivatives |
| 04/06/2010 | CA2453383C Piperidine derivatives as nmda receptor antagonists |
| 04/01/2010 | WO2010035806A1 Solid pharmaceutical composition |
| 04/01/2010 | WO2010035769A1 Improved antibody molecule |
| 04/01/2010 | US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 04/01/2010 | US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 04/01/2010 | US20100081640 Pharmaceutical composition |
| 04/01/2010 | US20100081614 Long-acting growth hormone and methods of producing same |
| 04/01/2010 | US20100080822 treating menstrual cramps by administering composition of extracts from stem of Cinnamomum cassia, sclerotium of Poria cocos, root bark of Paeonia suffruticosa, root of Paeonia lactiflora and seed of Prunus persica or Prunus davidiana; composition comprises1.3-1.9% Paeoniflorin and 0.7-1.1% Paeonol |
| 04/01/2010 | US20100080811 Anti-myostatin antibodies |
| 04/01/2010 | CA2738147A1 Solid pharmaceutical composition |
| 03/31/2010 | EP2168984A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/31/2010 | EP2167508A1 Compounds for treating duchenne muscular dystrophy |
| 03/31/2010 | EP2167136A2 Molecules for targeting compounds to various selected organs or tissues |
| 03/31/2010 | EP2167135A2 Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| 03/31/2010 | EP1630165B1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF |
| 03/31/2010 | CN101687905A Pure rocuronium bromide |
| 03/31/2010 | CN101686919A Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
| 03/31/2010 | CN101684158A Binding domain-immunoglobulin fusion proteins |
| 03/31/2010 | CN100596297C Technology for extracting dihydrogalanthamine from lycoris radiata genus plant |
| 03/30/2010 | US7687505 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 03/30/2010 | US7687485 Formulation for menopausal women |
| 03/30/2010 | US7687059 Systems and methods for treating patients with processed lipoaspirate cells |
| 03/30/2010 | CA2380673C Compositions comprising modafinil for treatment of attention deficit hyperactivity disorder |
| 03/25/2010 | WO2010031190A1 Culture medium for myoblasts, precursors thereof and derivatives thereof |
| 03/25/2010 | WO2010008733A3 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 03/25/2010 | WO2010004283A3 Sulfonylurea receptor and means for treating ischaemia |
| 03/25/2010 | WO2009155056A3 Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 03/25/2010 | US20100076043 Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use |
| 03/25/2010 | US20100075959 Benzothiazole derivatives with activity as adenosine receptor ligands |
| 03/25/2010 | US20100075938 Use of Chemical Chelators as Reversal Agents for Drug-Induced Neuromuscular Block |
| 03/24/2010 | EP2166003A1 Excitatory amino acid receptor antagonists |
| 03/24/2010 | CN101678047A Remedy and diagnostic for mitochondrial dysfunction brain disease |
| 03/24/2010 | CN101676286A Azaindoles useful as inhibitors of JAK and other protein kinases |
| 03/24/2010 | CN101675927A therapeutic molecules and methods-1 |
| 03/23/2010 | US7683163 Colchicoside analogues |
| 03/23/2010 | CA2610821C Organic salts of .beta.-alanine |
| 03/18/2010 | WO2010028981A1 New benzimidazole derivatives |
| 03/18/2010 | US20100069404 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS |
| 03/18/2010 | US20100069386 Modulators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
| 03/18/2010 | US20100068232 Methods for treating skin lines and wrinkles and improving skin quality |
| 03/18/2010 | US20100068177 Methods of organ regeneration |
| 03/18/2010 | CA2734034A1 New benzimidazole derivatives |
| 03/17/2010 | EP1315502B1 Method for treating erectile dysfunction and increasing libido in men |
| 03/17/2010 | EP1303536B1 Novel fibroblast growth factor (fgf23) and methods for use |
| 03/17/2010 | CN100594027C Percutaneous medicine of strychnine, toxiferine, securinine and salt thereof |
| 03/16/2010 | US7678834 Substituted 4-aminocyclohexanol compounds |
| 03/16/2010 | CA2576734C Use of alk 5 inhibitors to modulate or inhibit myostatin activity leading to increased lean tissue accretion in animals |
| 03/16/2010 | CA2386980C Benzodiazepine derivatives for use in acute or chronic neurological disorders |
| 03/16/2010 | CA2372575C Bradykinin receptor antagonists |
| 03/11/2010 | WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity |
| 03/11/2010 | US20100063120 Imidazolidine Derivatives, Uses Therefor, Preparation Thereof and Compositions Comprising Such |
| 03/11/2010 | US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators |
| 03/11/2010 | US20100063062 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |